Learn about how NUCALA (mepolizumab) can decrease airway inflammation that may trigger severe asthma attacks. NUCALA is not used for sudden breathing problems.
hours; leukotriene receptor antagonists (LTRAs), such as montelukast or zafirlukast; slow-release theophylline; long-acting muscarinic receptor antagonists (LAMAs) such as tiotropium bromide or glycopyrronium bromide; with biologics such as omalizumab, mepolizumab, reslizumab, benralizumab, or ...
Nucala (mepolizumab), formerly known as Bosatria, is a monoclonal antibody again interleukin-5 (IL-5)16 Cinqair (reslizumab), another monoclonal antibody against the IL-5 receptor17 Xolair(omalizumab): indicated to treat moderate-to-severe persistent asthma in patients 6 years old or older18 ...
nasal polyposis; review; epidemiology; paraclinic assessment; management; intranasal corticosteroids; surgery; biologics; omalizumab; mepolizumab; dupilumab1. Introduction Sinonasal polyposis is a distinct form of chronic rhinosinusitis characterized by various phenotypes and endotypes [1,2]. Chronic ...